Literature DB >> 16354585

A review of the past, present, and future directions of neoplasia.

Alnawaz Rehemtulla1, Brian D Ross.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16354585      PMCID： PMC1501177          DOI： 10.1593/neo.05793

Source DB:  PubMed          Journal:  Neoplasia        ISSN： 1476-5586            Impact factor:   5.715


× No keyword cloud information.
  247 in total

1.  A theoretical model for intraperitoneal delivery of cisplatin and the effect of hyperthermia on drug penetration distance.

Authors:  Ardith W El-Kareh; Timothy W Secomb
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

2.  A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe.

Authors:  Shanta M Messerli; Shilpa Prabhakar; Yi Tang; Khalid Shah; Maria L Cortes; Vidya Murthy; Ralph Weissleder; Xandra O Breakefield; Ching-Hsuan Tung
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

3.  Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI.

Authors:  Yael Mardor; Yiftach Roth; Aharon Ochershvilli; Roberto Spiegelmann; Thomas Tichler; Dianne Daniels; Stephan E Maier; Ouzi Nissim; Zvi Ram; Jacob Baram; Arie Orenstein; Raphael Pfeffer
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

4.  Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model.

Authors:  Nasim Akhtar; Marcia L Padilla; Erin B Dickerson; Howard Steinberg; Matthew Breen; Robert Auerbach; Stuart C Helfand
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

5.  Methylation of a CpG island within the uroplakin Ib promoter: a possible mechanism for loss of uroplakin Ib expression in bladder carcinoma.

Authors:  Andrea E Varga; Lefta Leonardos; Paul Jackson; Alexandra Marreiros; Prue A Cowled
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

6.  Upregulation of survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis.

Authors:  Anmol Chandele; Vandna Prasad; Jayashree C Jagtap; Ravi Shukla; Padma R Shastry
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

7.  Zoning of mucosal phenotype, dysplasia, and telomerase activity measured by telomerase repeat assay protocol in Barrett's esophagus.

Authors:  James J Going; Aileen J Fletcher-Monaghan; Lisa Neilson; Bea A Wisman; Ate van der Zee; Robert C Stuart; W Nicol Keith
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

8.  15-lipoxygenase-1 expression upregulates and activates insulin-like growth factor-1 receptor in prostate cancer cells.

Authors:  Uddhav P Kelavkar; Cynthia Cohen
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

9.  Calpain activity is generally elevated during transformation but has oncogene-specific biological functions.

Authors:  N O Carragher; B D Fonseca; M C Frame
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

10.  L-type amino acid transporter-1 overexpression and melphalan sensitivity in Barrett's adenocarcinoma.

Authors:  Jules Lin; Duna A Raoof; Dafydd G Thomas; Joel K Greenson; Thomas J Giordano; Gregory S Robinson; Maureen J Bourner; Christopher T Bauer; Mark B Orringer; David G Beer
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715
View more
  1 in total

1.  Inhibition of eIF2α dephosphorylation enhances TRAIL-induced apoptosis in hepatoma cells.

Authors:  Y Teng; M Gao; J Wang; Q Kong; H Hua; T Luo; Y Jiang
Journal:  Cell Death Dis       Date:  2014-02-13       Impact factor: 8.469
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.